We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Supercomputers Help Estimate Astronauts Radiation Risk

By HospiMedica International staff writers
Posted on 19 Apr 2018
A new study reveals that a space vehicle with relatively minimal shielding and a high inclination polar orbit could expose astronauts to high exposures of cosmic radiation and solar particle events.

Researchers at Texas A&M University (TAMU; College Station, TX, USA), the U.S. More...
National Aeronautics and Space Administration (NASA; Houston, USA), and the Mayo Clinic Arizona (Scottsdale, USA) investigated potential radiation risks facing astronauts that would have operated the Manned Orbiting Laboratory (MOL), a mission planned by NASA in the 1960’s, but which never actually flew. Mission documents were recently declassified.

The MOL was conceived as an experimental laboratory for human spaceflight, but was recast as a secret reconnaissance platform in 1965 during the height of the Cold War. The vehicle would have travelled in low-earth orbit and passed repeatedly over the northern and southern polar regions to better spy on the Soviet Union. In August 1972, three years after the MOL mission planning was discontinued due to the emergence of cheaper, unmanned satellites, the Earth experienced a historically large solar particle event. The researchers explored how typical radiation and a solar flare from would have impacted MOL pilots.

They focused on radiation from two sources: solar particle events (SPEs) and galactic cosmic rays (GCRs). The researchers first modeled the MOL's orbit profile, the space weather and geomagnetic forces from those years, and the particle and heavy ion transport that such a trajectory would have encountered. Then, using a supercomputer requiring 150,000 computational hours, they found that under normal conditions, the MOL crew would have endured 113.6 millisievert (mSv) to their skin and 41.6 mSv to blood forming organs during a 30-day flight, well within the exposure limits for NASA astronauts.

However, during the "worst-case scenario" of the 1972 solar storm, their skin would have been exposed to 1,770 mSv, while their organs would have experienced 451 mSv, toxic doses of radiation. Based on animal studies, they concluded that such exposure would have caused nausea, vomiting, fatigue, and possibly skin burns to crew. Without rapid instigation of medical countermeasures, the risks could have been even more severe, affecting both short and long-term human health. The study was published on April 4, 2018, in npj Microgravity.

“Given the intended future of human spaceflight, with efforts now to rapidly expand capabilities for human missions to the moon and Mars, there is a pressing need to improve upon the understanding of the space radiation risk,” said lead author Jeffery Chancellor, MSc, of the TAMU department of physics and astronomy. “I think the research will have a huge impact for commercial space flight. It gives some insight to people who are trying to come up with ideas for orbiting hotels, or to SpaceX or Virgin Galactic who want to do tourist flights, in terms of what they have to address in order to protect the crew and customers.”

Accelerated ions in cosmic radiation interact differently with objects and people. While X-rays can be blocked by lead shields, GCR ions can become more dangerous when interacting with metals, generating secondary particles that have biological effects, such as an accelerated development of atherosclerosis, rapid progression of advanced aortic root lesions, reduced lesional collagen, and intima media thickening of the carotid arteries. Space travel also affects other organs; the heart, for example, changes shape and becomes more spherical.

Related Links:
Texas A&M University
U.S. National Aeronautics and Space Administration
Mayo Clinic Arizona

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Hybrid Arch Device
Neo EDE
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Illustration of the Hēlo Thrombectomy System device (Photo courtesty of Endovascular Engineering)

FDA-Cleared Thrombectomy System Removes Pulmonary Embolism Clots

Pulmonary embolism occurs when blood clots travel to the lungs and block blood flow, potentially requiring urgent endovascular intervention to prevent death. Catheter-based clot removal can be challenging,... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.